Each request will be reviewed by the PLIS data steering committee, and approved access will require a formal data use agreement
In patients with type 1 diabetes, intensive glycemic control with an A1C goal of approximately 7% reduces the risk of symptomatic neuropathy by up to 60%
Piperi C, Adamopoulos C, Dalagiorgou G, Diamanti-Kandarakis E, Papavassiliou AG
Both medications treat obesity and many related metabolic conditions, Isaacs said
A clinician will assess whether Ozempic is clinically appropriate, and if not, may recommend an alternative such as Trulicity, Mounjaro, or oral diabetes medications
It is approved for weight management in adults and pediatric patients 12 years and older with obesity, as well as adults with overweight who have at least one weight-related health condition